Shanxi C&Y Pharmaceutical Group Co (SZSE:300254) LT-Debt-to-Total-Asset : 0.11 (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Shanxi C&Y Pharmaceutical Group Co LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Shanxi C&Y Pharmaceutical Group Co's long-term debt to total assests ratio for the quarter that ended in Mar. 2024 was 0.11.

Shanxi C&Y Pharmaceutical Group Co's long-term debt to total assets ratio declined from Mar. 2023 (0.11) to Mar. 2024 (0.11). It may suggest that Shanxi C&Y Pharmaceutical Group Co is progressively becoming less dependent on debt to grow their business.

Shanxi C&Y Pharmaceutical Group Co LT-Debt-to-Total-Asset Historical Data

The historical data trend for Shanxi C&Y Pharmaceutical Group Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanxi C&Y Pharmaceutical Group Co LT-Debt-to-Total-Asset Chart

Shanxi C&Y Pharmaceutical Group Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.11

0.06

0.03

0.12

0.11

Shanxi C&Y Pharmaceutical Group Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.11	0.11	0.10	0.11	0.11

Shanxi C&Y Pharmaceutical Group Co LT-Debt-to-Total-Asset Calculation

Shanxi C&Y Pharmaceutical Group Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	158.785	/	1433.075
	=	0.11

Shanxi C&Y Pharmaceutical Group Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (Q: Mar. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2024 )	/	Total Assets (Q: Mar. 2024 )
	=	155.339	/	1476.234
	=	0.11

Shanxi C&Y Pharmaceutical Group Co (SZSE:300254) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Shanxi C&Y Pharmaceutical Group Co LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Shanxi C&Y Pharmaceutical Group Co's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanxi C&Y Pharmaceutical Group Co (SZSE:300254) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanxi C&Y Pharmaceutical Group Co Ltd (SZSE:300254) » Definitions » LT-Debt-to-Total-Asset

Traded in Other Exchanges

N/A

Address

No.53, Hubin Street, Economic and Technological Development Zone, Datong, CHN, 037010

Website

http://www.cy-pharm.com

Shanxi C&Y Pharmaceutical Group Co Ltd is engaged in the production, research and development, and sales of pharmaceutical products. The company offers pregnancy products and services, anti-infective, and urinary health.

Executives

Zuo Xue Min	Supervisors
Huang Le Qun	Director
Zhang Zhen Biao	Executives
Yu Jun Xian	Directors, Directors, and Executives
Zhao Qun	Director
Weng Zhan Guo	Director
Geng Chun Feng	Director
Pang Xiao Quan	Supervisors
Zhong Hai Rong	Directors, executives
Xuan Hang	Director

Shanxi C&Y Pharmaceutical Group Co (SZSE:300254) Headlines

No Headlines